Evidence for the requirement for CD40-CD154 interactions in resistance to infections with attenuated Salmonella

Journal of Endotoxin Research

Volumn 11, Issue 6, 2005, Pages 395-399

  Fernandez Cabezudo, Maria J ^a   Ullah, Azim ^a   Flavell, Richard A ^b   Al Ramadi, Basel K ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial; Co stimulation; Cytokines; Th1 Th2 cells; Vaccination

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; NITRIC OXIDE; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; GROWTH INHIBITION; HOST CELL; HOST RESISTANCE; HUMORAL IMMUNITY; IN VIVO STUDY; INNATE IMMUNITY; MOUSE; NONHUMAN; RETICULOENDOTHELIAL SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; STATISTICAL ANALYSIS; SURVIVAL RATE;

ACUTE-PHASE REACTION; ANIMALS; ANTIGENS, CD40; CD40 LIGAND; CELLS, CULTURED; CULTURE MEDIA; CYTOKINES; DISEASE SUSCEPTIBILITY; IMMUNITY, ACTIVE; IMMUNITY, NATURAL; INTERFERON TYPE II; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; SEROTYPING; SPLEEN; SURVIVAL RATE; TH1 CELLS; TIME FACTORS; VACCINES, ATTENUATED;

ANIMALIA; BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 28444433403     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805105X67319     Document Type: Article

References (31)

1. Grewal IS, Xu J, Flavell RA. Impairment of antigen-specific T cell priming in mice lacking CD40 ligand. Nature 1995; 348: 617-620.
2. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 1996; 14: 591-617.
3. van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67: 2-17.
4. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16: 111-135.
5. Soong L, Xu JC, Grewal IS et al. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 1996; 4: 263-273.
6. Kamanaka M, Yu P, Yasui T et al. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 1996; 4: 275-281.
7. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 1996; 4: 283-289.
8. Campos-Neto A, Ovendale P, Bement T et al. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J Immunol 1998; 160: 2037-2041.
9. Zhou P, Seder RA. CD40 ligand is not essential for induction of type 1 cytokine responses or protective immunity after primary or secondary infection with Histoplasma capsulatum. J Exp Med 1998; 187: 1315-1324.
10. Eisenstein TK, Killar LM, Sultzer BM. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J Infect Dis 1984;150: 425-435.
11. Mastroeni P, Villarreal-Ramos B, Hormaeche CE. Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells. Infect Immun 1993; 61: 3981-3984.
12. Xu J, Foy TM, Laman JD et al. Mice deficient for the CD40 ligand. Immunity 1994; 1: 423-431.
13. al-Ramadi BK, Al-Dhaheri MH, Mustafa N et al. Influence of vector-encoded cytokines on anti-Salmonella immunity: divergent effects of interleukin-2 and tumor necrosis factor alpha. Infect Immun 2001; 69: 3980-3988.
14. al-Ramadi BK, Bashir G, Rizvi T, Femandez-Cabezudo MJ. Poor survival but high immunogenicity of IL-2-expressing Salmonella typhimurium in inherently resistant mice. Microbes Infect 2004; 6: 350-359.
15. Strugnell R, Dougan G, Chatfield S et al. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect Immun 1992; 60: 3994-4002.
16. Hoiseth SK, Stocker BAD. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981; 291: 238-239.
17. al-Ramadi BK, Mustafa N, AbouHaidar M, Fernandez-Cabezudo MJ. Induction of innate immunity by IL-2-expressing Salmonella confers protection against lethal infection. Mol Immunol 2003; 39: 763-770.
18. al-Ramadi BK, Fernandez-Cabezudo MJ, Mustafa N, Xu D. Activation of innate immune responses by IL-2-expressing Salmonella typhimurium is independent of Toll-like receptor 4. Mol Immunol 2004; 40: 671-679.
19. Marriott I, Thomas EK, Bost KL. CD40-CD40 ligand interactions augment survival of normal mice, but not CD40 ligand knockout mice, challenged orally with Salmonella dublin. Infect Immun 1999; 67: 5253-5257.
20. Raupach B, Kaufmann SHE. Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain? Microbes Infect 2001; 3: 1261-1269.
21. Shu U, Kiniwa M, Wu CY et al. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995; 25: 1125-1128.
22. Kato T, Hakamada R, Yamane H, Nariuchi H. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J Immunol 1996; 156: 3932-3938.
23. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747-752.
24. Koch F, Stanzl U, Jennewein P et al. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996; 184: 741-746.
25. Sinha K, Mastroeni P, Harrison J, Demarco de Hormaeche R, Hormaeche CE. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Infect Immun 1997; 65: 1566-1569.
26. + TCR-αβ cells and IFN-γ in bacterial clearance independent of intracellular location. J Immunol 1996; 156: 3321-3326.
27. Mittrucker H-W, Kohler A, Mak TW, Kaufmann SHE. Critical role of CD28 in protective immunity against Salmonella typhimurium. J Immunol 1999; 163: 6769-6776.
28. McSorley SJ, Jenkins MK. Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar Typhimurium. Infect Immun 2000; 68: 3344-3348.
29. Conlan JW. Neutrophils prevent extracellular colonization of the liver microvasculature by Salmonella typhimurium. Infect Immun 1996; 64: 1043-1047.
30. Mastroeni P, Sheppard M. Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues. Microbes Infect 2004; 6: 398-405.
31. Eckmann L, Kagnoff MF. Cytokines in host defense against Salmonella. Microbes Infect 2001; 3: 1191-1200.